AIM ImmunoTech Announces $2.65 Million At-Market Financing to Advance Clinical Trials and Drug Development 1
AIM ImmunoTech Announces \$2.65 Million At-Market Financing:...
Sign in to continue:
AIM ImmunoTech Announces \$2.65 Million At-Market Financing:...
Morgan Stanley Bitcoin Trust Announces Board Changes and New...
Shake Shack Inc. Announces Results of 2026 Annual Meeting of...
Amalgamated Financial Corp. Announces Major Expansion of Sha...
Chimera Investment Corporation 8-K: 2026 Annual Meeting & Sh...
RideNow Group, Inc. Announces Change in Independent Auditor;...
Zomedica Corp. Announces Results of 2026 Annual Shareholder ...
Organon & Co. Announces Shareholder Approval of Amended 2021...
Zedge, Inc. Q3 Fiscal 2026 Earnings Report – Investor Analys...
Build-A-Bear Workshop Declares Quarterly Dividend Buil...